CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,087
- in 3 filings
Net −$296,087. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 76 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-06 | Paul Robert Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −30,000 | 99,549 | ||
| 2021-07-06 | Yu Calvin Vice President, Finance | Option exercise | +1,042 | $8.16 | $9K | 77,728 |
| 2021-07-06 | Yu Calvin Vice President, Finance | Option exercise | +625 | $10.14 | $6K | 78,353 |
| 2021-07-06 | Yu Calvin Vice President, Finance | Option exercise | +1,667 | $17.15 | $29K | 80,020 |
| 2021-07-06 | Yu Calvin Vice President, Finance | Sale | −3,334 | $34.65 | $116K | 76,686 |
| 2021-07-06 | Yu Calvin Vice President, Finance | Option exercise · Employee Stock Option (right to buy) | −1,042 | 13,076 | ||
| 2021-07-06 | Yu Calvin Vice President, Finance | Option exercise · Employee Stock Option (right to buy) | −625 | 10,000 | ||
| 2021-07-06 | Yu Calvin Vice President, Finance | Option exercise · Employee Stock Option (right to buy) | −1,667 | 47,163 | ||
| 2021-07-02 | SCHELLER RICHARD H Director | Sale | −9,981 | $31.14 | $311K | 0 |
| 2021-07-02 | Yu Calvin Vice President, Finance | Option exercise | +18,420 | $8.16 | $150K | 145,106 |
| 2021-07-02 | Yu Calvin Vice President, Finance | Option exercise | +11,250 | $10.14 | $114K | 156,356 |
| 2021-07-02 | Yu Calvin Vice President, Finance | Option exercise | +31,170 | $17.15 | $535K | 187,526 |
| 2021-07-02 | Yu Calvin Vice President, Finance | Sale | −90,840 | $31.14 | $2.8M | 96,686 |
| 2021-07-02 | Yu Calvin Vice President, Finance | Sale | −20,000 | $40.02 | $800K | 76,686 |
| 2021-07-02 | Yu Calvin Vice President, Finance | Option exercise · Employee Stock Option (right to buy) | −18,420 | 14,118 | ||
| 2021-07-02 | Yu Calvin Vice President, Finance | Option exercise · Employee Stock Option (right to buy) | −11,250 | 10,625 | ||
| 2021-07-02 | Yu Calvin Vice President, Finance | Option exercise · Employee Stock Option (right to buy) | −31,170 | 48,830 | ||
| 2021-07-02 | King Robert Chief Development Officer | Option exercise | +30,000 | $8.16 | $245K | 552,317 |
| 2021-07-02 | King Robert Chief Development Officer | Option exercise | +30,000 | $10.14 | $304K | 582,317 |
| 2021-07-02 | King Robert Chief Development Officer | Sale | −60,000 | $31.14 | $1.9M | 522,317 |
Page 18 of 23 · 454 trades